Literature DB >> 1945416

Occurrence of Ki-ras and p53 mutations in primary colorectal tumors.

P Shaw1, S Tardy, E Benito, A Obrador, J Costa.   

Abstract

Twenty-four colorectal tumors and their paired mucosa were examined for allele loss on chromosomes 5 and 17, using polymerase chain reaction-amplified DNA, and for mutations in the Ki-ras and p53 genes. In addition, 19 benign polyps were analysed for mutations in the p53 gene. RFLP analysis of the long arm of chromosome 5 indicated an allele loss frequency of 47% for malignant tumors, a value somewhat higher than previously observed. Examination of the short arm of chromosome 17 indicated an allele loss of 60%. Sequence analysis of the p53 gene in colorectal tumors indicated that 64% contained a mutation. All tumors showing allele loss on chromosome 17 were mutant for p53, suggesting that mutation of one p53 allele precedes the hemizygotic loss of the wild-type allele. Sequence analysis of the p53 gene in 19 benign polyps, devoid of severe dysplasia, did not reveal any mutants, suggesting that the mutation of one p53 allele is an event that takes place after polyp formation. Ki-ras mutations were observed in 48% of the tumors examined. All tumors which were mutant for Ki-ras, except for one, were also mutant for p53.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1945416

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  20 in total

1.  Association Between Specific Mutations in KRAS Codon 12 and Colorectal Liver Metastasis.

Authors:  Georgios Antonios Margonis; Yuhree Kim; Gaya Spolverato; Aslam Ejaz; Rohan Gupta; David Cosgrove; Robert Anders; Georgios Karagkounis; Michael A Choti; Timothy M Pawlik
Journal:  JAMA Surg       Date:  2015-08       Impact factor: 14.766

2.  Immunoreactivity for p53 and mdm2 and the detection of p53 mutations in human malignant mesothelioma.

Authors:  K Segers; H Backhovens; S K Singh; J De Voecht; M Ramael; C Van Broeckhoven; E Van Marck
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

3.  Oncogenic RAS-induced downregulation of ATG12 is required for survival of malignant intestinal epithelial cells.

Authors:  Byong Hoon Yoo; Iman Aftab Khan; Ananda Koomson; Pramod Gowda; Takehiko Sasazuki; Senji Shirasawa; Shashi Gujar; Kirill V. Rosen
Journal:  Autophagy       Date:  2017-12-21       Impact factor: 16.016

4.  Differential gene expression of chemokines in KRAS and BRAF mutated colorectal cell lines: role of cytokines.

Authors:  Sajjad Khan; Silke Cameron; Martina Blaschke; Federico Moriconi; Naila Naz; Ahmad Amanzada; Giuliano Ramadori; Ihtzaz Ahmed Malik
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

5.  Mutations in epidermal growth factor receptor and K-ras in Chinese patients with colorectal cancer.

Authors:  Zuo Yunxia; Cao Jun; Zhu Guanshan; Lu Yachao; Zhou Xueke; Li Jin
Journal:  BMC Med Genet       Date:  2010-02-26       Impact factor: 2.103

6.  Does Mutated K-RAS Oncogene Attenuate the Effect of Sulindac in Colon Cancer Chemoprevention?

Authors:  Photini F S Rice; Kevin G Ehrichs; Mykella S Jones; Hwudarw Chen; Chiu-Hsieh Hsu; Edward R Abril; Raymond B Nagle; David G Besselsen; Jennifer K Barton; Natalia A Ignatenko
Journal:  Cancer Prev Res (Phila)       Date:  2017-11-08

7.  K-ras mutations and p53 alterations in neoplastic and nonneoplastic lesions associated with longstanding ulcerative colitis.

Authors:  P Chaubert; J Benhattar; E Saraga; J Costa
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

8.  KRAS mutations and subtyping in colorectal cancer in Jordanian patients.

Authors:  Wafa M Elbjeirami; Maher A Sughayer
Journal:  Oncol Lett       Date:  2012-07-04       Impact factor: 2.967

9.  Caveolin-1 is a novel regulator of K-RAS-dependent migration in colon carcinogenesis.

Authors:  Upal K Basu Roy; Rebecca S Henkhaus; Fotios Loupakis; Chiara Cremolini; Eugene W Gerner; Natalia A Ignatenko
Journal:  Int J Cancer       Date:  2013-02-12       Impact factor: 7.396

10.  High frequency of K-ras mutations in sporadic colorectal adenomas.

Authors:  E A McLellan; R A Owen; K A Stepniewska; J P Sheffield; N R Lemoine
Journal:  Gut       Date:  1993-03       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.